BRIC Clinical Chemistry Market Outlook to 2024

Published : Dec-2017

No. of Pages : 332

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 12
2.1 What Is This Report About? 12
2.2 Clinical Chemistry Market Segmentation 12
2.3 Definitions of Markets Covered in the Report 14
3 Clinical Chemistry Market, BRIC 19
3.1 Clinical Chemistry Market, BRIC, Revenue ($m), 2010-2024 19
3.2 Clinical Chemistry Market, BRIC, Category Comparison by Revenue ($m), 2010-2024 21
3.3 Clinical Chemistry Market, BRIC, Revenue ($m), 2010-2017 23
3.4 Clinical Chemistry Market, BRIC, Revenue ($m), 2017-2024 25
3.5 Clinical Chemistry Market, BRIC, Volume (Units), 2010-2024 27
3.6 Clinical Chemistry Market, BRIC, Volume (Units), 2010-2017 29
3.7 Clinical Chemistry Market, BRIC, Volume (Units), 2017-2024 31
3.8 Clinical Chemistry Market, BRIC, Company Share by Revenue ($m), 2017 33
4 Clinical Chemistry Market, Brazil 35
4.1 Clinical Chemistry Market, Brazil, Revenue ($m), 2010-2017 35
4.2 Clinical Chemistry Market, Brazil, Revenue ($m), 2017-2024 37
4.2.1 Blood Test Strips - Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2010-2017 39
4.2.2 Clinical Chemistry Analyzers Market, Brazil, Revenue ($m), by Segment, 2010-2017 41
4.2.3 Enzyme Chemistry Reagents Market, Brazil, Revenue ($m), by Segment, 2010-2017 43
4.2.4 Feces Tests - Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2010-2017 45
4.2.5 Substrates Market, Brazil, Revenue ($m), by Segment, 2010-2017 47
4.2.6 Therapeutic Drug Monitoring Market, Brazil, Revenue ($m), by Segment, 2010-2017 49
4.2.7 Urine Analysis Market, Brazil, Revenue ($m), by Segment, 2010-2017 51
4.2.8 Urine Testing - Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2010-2017 53
4.2.9 Blood Test Strips - Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2017-2024 55
4.2.10 Clinical Chemistry Analyzers Market, Brazil, Revenue ($m), by Segment, 2017-2024 57
4.2.11 Enzyme Chemistry Reagents Market, Brazil, Revenue ($m), by Segment, 2017-2024 59
4.2.12 Feces Tests - Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2017-2024 61
4.2.13 Substrates Market, Brazil, Revenue ($m), by Segment, 2017-2024 63
4.2.14 Therapeutic Drug Monitoring Market, Brazil, Revenue ($m), by Segment, 2017-2024 65
4.2.15 Urine Analysis Market, Brazil, Revenue ($m), by Segment, 2017-2024 67
4.2.16 Urine Testing - Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2017-2024 69
4.3 Clinical Chemistry Market, Brazil, Volume (Units), 2010-2017 71
4.4 Clinical Chemistry Market, Brazil, Volume (Units), 2017-2024 73
4.4.1 Blood Test Strips - Rapid Tests & POC Market, Brazil, Volume (Units), by Segment, 2010-2017 75
4.4.2 Clinical Chemistry Analyzers Market, Brazil, Volume (Units), by Segment, 2010-2017 77
4.4.3 Enzyme Chemistry Reagents Market, Brazil, Volume (Units), by Segment, 2010-2017 79
4.4.4 Feces Tests - Rapid Tests & POC Market, Brazil, Volume (Units), by Segment, 2010-2017 81
4.4.5 Substrates Market, Brazil, Volume (Units), by Segment, 2010-2017 83
4.4.6 Urine Testing - Rapid Tests & POC Market, Brazil, Volume (Units), by Segment, 2010-2017 85
4.4.7 Blood Test Strips - Rapid Tests & POC Market, Brazil, Volume (Units), by Segment, 2017-2024 87
4.4.8 Clinical Chemistry Analyzers Market, Brazil, Volume (Units), by Segment, 2017-2024 89
4.4.9 Enzyme Chemistry Reagents Market, Brazil, Volume (Units), by Segment, 2017-2024 91
4.4.10 Feces Tests - Rapid Tests & POC Market, Brazil, Volume (Units), by Segment, 2017-2024 93
4.4.11 Substrates Market, Brazil, Volume (Units), by Segment, 2017-2024 95
4.4.12 Urine Testing - Rapid Tests & POC Market, Brazil, Volume (Units), by Segment, 2017-2024 97
4.5 Clinical Chemistry Market, Brazil, Average Price ($), 2010-2024 99
4.6 Clinical Chemistry Market, Brazil, Distribution Share by Revenue ($m), 2017 104
4.7 Clinical Chemistry Market, Brazil, Company Share by Revenue ($m), 2017 105
5 Clinical Chemistry Market, China 107
5.1 Clinical Chemistry Market, China, Revenue ($m), 2010-2017 107
5.2 Clinical Chemistry Market, China, Revenue ($m), 2017-2024 109
5.2.1 Blood Test Strips - Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2010-2017 111
5.2.2 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2010-2017 113
5.2.3 Enzyme Chemistry Reagents Market, China, Revenue ($m), by Segment, 2010-2017 115
5.2.4 Feces Tests - Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2010-2017 117
5.2.5 Substrates Market, China, Revenue ($m), by Segment, 2010-2017 119
5.2.6 Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2010-2017 121
5.2.7 Urine Analysis Market, China, Revenue ($m), by Segment, 2010-2017 123
5.2.8 Urine Testing - Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2010-2017 125
5.2.9 Blood Test Strips - Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2017-2024 127
5.2.10 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2017-2024 129
5.2.11 Enzyme Chemistry Reagents Market, China, Revenue ($m), by Segment, 2017-2024 131
5.2.12 Feces Tests - Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2017-2024 133
5.2.13 Substrates Market, China, Revenue ($m), by Segment, 2017-2024 135
5.2.14 Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2017-2024 137
5.2.15 Urine Analysis Market, China, Revenue ($m), by Segment, 2017-2024 139
5.2.16 Urine Testing - Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2017-2024 141
5.3 Clinical Chemistry Market, China, Volume (Units), 2010-2017 143
5.4 Clinical Chemistry Market, China, Volume (Units), 2017-2024 145
5.4.1 Blood Test Strips - Rapid Tests & POC Market, China, Volume (Units), by Segment, 2010-2017 147
5.4.2 Clinical Chemistry Analyzers Market, China, Volume (Units), by Segment, 2010-2017 149
5.4.3 Enzyme Chemistry Reagents Market, China, Volume (Units), by Segment, 2010-2017 151
5.4.4 Feces Tests - Rapid Tests & POC Market, China, Volume (Units), by Segment, 2010-2017 153
5.4.5 Substrates Market, China, Volume (Units), by Segment, 2010-2017 155
5.4.6 Urine Testing - Rapid Tests & POC Market, China, Volume (Units), by Segment, 2010-2017 157
5.4.7 Blood Test Strips - Rapid Tests & POC Market, China, Volume (Units), by Segment, 2017-2024 159
5.4.8 Clinical Chemistry Analyzers Market, China, Volume (Units), by Segment, 2017-2024 161
5.4.9 Enzyme Chemistry Reagents Market, China, Volume (Units), by Segment, 2017-2024 163
5.4.10 Feces Tests - Rapid Tests & POC Market, China, Volume (Units), by Segment, 2017-2024 165
5.4.11 Substrates Market, China, Volume (Units), by Segment, 2017-2024 167
5.4.12 Urine Testing - Rapid Tests & POC Market, China, Volume (Units), by Segment, 2017-2024 169
5.5 Clinical Chemistry Market, China, Average Price ($), 2010-2024 171
5.6 Clinical Chemistry Market, China, Distribution Share by Revenue ($m), 2017 177
5.7 Clinical Chemistry Market, China, Company Share by Revenue ($m), 2017 178
6 Clinical Chemistry Market, India 180
6.1 Clinical Chemistry Market, India, Revenue ($m), 2010-2017 180
6.2 Clinical Chemistry Market, India, Revenue ($m), 2017-2024 182
6.2.1 Blood Test Strips - Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2010-2017 184
6.2.2 Clinical Chemistry Analyzers Market, India, Revenue ($m), by Segment, 2010-2017 186
6.2.3 Enzyme Chemistry Reagents Market, India, Revenue ($m), by Segment, 2010-2017 188
6.2.4 Feces Tests - Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2010-2017 190
6.2.5 Substrates Market, India, Revenue ($m), by Segment, 2010-2017 192
6.2.6 Therapeutic Drug Monitoring Market, India, Revenue ($m), by Segment, 2010-2017 194
6.2.7 Urine Analysis Market, India, Revenue ($m), by Segment, 2010-2017 196
6.2.8 Urine Testing - Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2010-2017 198
6.2.9 Blood Test Strips - Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2017-2024 200
6.2.10 Clinical Chemistry Analyzers Market, India, Revenue ($m), by Segment, 2017-2024 202
6.2.11 Enzyme Chemistry Reagents Market, India, Revenue ($m), by Segment, 2017-2024 204
6.2.12 Feces Tests - Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2017-2024 206
6.2.13 Substrates Market, India, Revenue ($m), by Segment, 2017-2024 208
6.2.14 Therapeutic Drug Monitoring Market, India, Revenue ($m), by Segment, 2017-2024 210
6.2.15 Urine Analysis Market, India, Revenue ($m), by Segment, 2017-2024 212
6.2.16 Urine Testing - Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2017-2024 214
6.3 Clinical Chemistry Market, India, Volume (Units), 2010-2017 216
6.4 Clinical Chemistry Market, India, Volume (Units), 2017-2024 218
6.4.1 Blood Test Strips - Rapid Tests & POC Market, India, Volume (Units), by Segment, 2010-2017 220
6.4.2 Clinical Chemistry Analyzers Market, India, Volume (Units), by Segment, 2010-2017 222
6.4.3 Enzyme Chemistry Reagents Market, India, Volume (Units), by Segment, 2010-2017 224
6.4.4 Feces Tests - Rapid Tests & POC Market, India, Volume (Units), by Segment, 2010-2017 226
6.4.5 Substrates Market, India, Volume (Units), by Segment, 2010-2017 228
6.4.6 Urine Testing - Rapid Tests & POC Market, India, Volume (Units), by Segment, 2010-2017 230
6.4.7 Blood Test Strips - Rapid Tests & POC Market, India, Volume (Units), by Segment, 2017-2024 232
6.4.8 Clinical Chemistry Analyzers Market, India, Volume (Units), by Segment, 2017-2024 234
6.4.9 Enzyme Chemistry Reagents Market, India, Volume (Units), by Segment, 2017-2024 236
6.4.10 Feces Tests - Rapid Tests & POC Market, India, Volume (Units), by Segment, 2017-2024 238
6.4.11 Substrates Market, India, Volume (Units), by Segment, 2017-2024 240
6.4.12 Urine Testing - Rapid Tests & POC Market, India, Volume (Units), by Segment, 2017-2024 242
6.5 Clinical Chemistry Market, India, Average Price ($), 2010-2024 244
6.6 Clinical Chemistry Market, India, Distribution Share by Revenue ($m), 2017 248
6.7 Clinical Chemistry Market, India, Company Share by Revenue ($m), 2017 249
7 Clinical Chemistry Market, Russia 251
7.1 Clinical Chemistry Market, Russia, Revenue ($m), 2010-2017 251
7.2 Clinical Chemistry Market, Russia, Revenue ($m), 2017-2024 253
7.2.1 Blood Test Strips - Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2010-2017 255
7.2.2 Clinical Chemistry Analyzers Market, Russia, Revenue ($m), by Segment, 2010-2017 257
7.2.3 Enzyme Chemistry Reagents Market, Russia, Revenue ($m), by Segment, 2010-2017 259
7.2.4 Feces Tests - Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2010-2017 261
7.2.5 Substrates Market, Russia, Revenue ($m), by Segment, 2010-2017 263
7.2.6 Therapeutic Drug Monitoring Market, Russia, Revenue ($m), by Segment, 2010-2017 265
7.2.7 Urine Analysis Market, Russia, Revenue ($m), by Segment, 2010-2017 267
7.2.8 Urine Testing - Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2010-2017 269
7.2.9 Blood Test Strips - Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2017-2024 271
7.2.10 Clinical Chemistry Analyzers Market, Russia, Revenue ($m), by Segment, 2017-2024 273
7.2.11 Enzyme Chemistry Reagents Market, Russia, Revenue ($m), by Segment, 2017-2024 275
7.2.12 Feces Tests - Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2017-2024 277
7.2.13 Substrates Market, Russia, Revenue ($m), by Segment, 2017-2024 279
7.2.14 Therapeutic Drug Monitoring Market, Russia, Revenue ($m), by Segment, 2017-2024 281
7.2.15 Urine Analysis Market, Russia, Revenue ($m), by Segment, 2017-2024 283
7.2.16 Urine Testing - Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2017-2024 285
7.3 Clinical Chemistry Market, Russia, Volume (Units), 2010-2017 287
7.4 Clinical Chemistry Market, Russia, Volume (Units), 2017-2024 289
7.4.1 Blood Test Strips - Rapid Tests & POC Market, Russia, Volume (Units), by Segment, 2010-2017 291
7.4.2 Clinical Chemistry Analyzers Market, Russia, Volume (Units), by Segment, 2010-2017 293
7.4.3 Enzyme Chemistry Reagents Market, Russia, Volume (Units), by Segment, 2010-2017 295
7.4.4 Feces Tests - Rapid Tests & POC Market, Russia, Volume (Units), by Segment, 2010-2017 297
7.4.5 Substrates Market, Russia, Volume (Units), by Segment, 2010-2017 299
7.4.6 Urine Testing - Rapid Tests & POC Market, Russia, Volume (Units), by Segment, 2010-2017 301
7.4.7 Blood Test Strips - Rapid Tests & POC Market, Russia, Volume (Units), by Segment, 2017-2024 303
7.4.8 Clinical Chemistry Analyzers Market, Russia, Volume (Units), by Segment, 2017-2024 305
7.4.9 Enzyme Chemistry Reagents Market, Russia, Volume (Units), by Segment, 2017-2024 307
7.4.10 Feces Tests - Rapid Tests & POC Market, Russia, Volume (Units), by Segment, 2017-2024 309
7.4.11 Substrates Market, Russia, Volume (Units), by Segment, 2017-2024 311
7.4.12 Urine Testing - Rapid Tests & POC Market, Russia, Volume (Units), by Segment, 2017-2024 313
7.5 Clinical Chemistry Market, Russia, Average Price ($), 2010-2024 315
7.6 Clinical Chemistry Market, Russia, Distribution Share by Revenue ($m), 2017 319
7.7 Clinical Chemistry Market, Russia, Company Share by Revenue ($m), 2017 320
8 Overview of Key Companies in BRIC Clinical Chemistry Market 322
8.1 F. Hoffmann-La Roche Ltd 322
8.1.1 Company Overview 322
8.2 Siemens Healthcare GmbH 322
8.2.1 Company Overview 322
8.3 Beckman Coulter Inc 322
8.3.1 Company Overview 322
8.4 Abbott Laboratories 322
8.4.1 Company Overview 322
8.5 Ortho-Clinical Diagnostics Inc 323
8.5.1 Company Overview 323
8.6 Sysmex Corp 323
8.6.1 Company Overview 323
8.7 Mindray Medical International Ltd 323
8.7.1 Company Overview 323
8.8 bioMerieux SA 323
8.8.1 Company Overview 323
8.9 Thermo Fisher Scientific Inc 324
8.9.1 Company Overview 324
8.10 Alere Inc 324
8.10.1 Company Overview 324
8.11 Randox Laboratories Ltd 324
8.11.1 Company Overview 324
9 Clinical Chemistry Market Pipeline Products 325
10 Appendix 326
10.1 Research Methodology 327
10.1.1 Coverage 327
10.1.2 Secondary Research 327
10.1.3 Primary Research 328
10.1.4 Market Modeling and Forecasting 329
10.1.5 Company Share Analysis 330
10.1.6 Distribution Share Analysis 331
10.1.7 Benchmarking 331
10.2 GlobalData Consulting 331
10.3 Contact Us 332
10.4 Disclaimer 332

1.1 List of Tables
Table 1: Clinical Chemistry Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2010-2024 20
Table 2: Clinical Chemistry Market, BRIC, Category Comparison by Revenue ($m), USD Constant, 2010-2024 22
Table 3: Clinical Chemistry Market, BRIC, Revenue ($m), Historic, USD Constant, 2010-2017 24
Table 4: Clinical Chemistry Market, BRIC, Revenue ($m), Forecast, USD Constant, 2017-2024 26
Table 5: Clinical Chemistry Market, BRIC, Volume (Units), 2010-2024 28
Table 6: Clinical Chemistry Market, BRIC, Volume (Units), Historic, 2010-2017 30
Table 7: Clinical Chemistry Market, BRIC, Volume (Units), Forecast, 2017-2024 32
Table 8: Clinical Chemistry Market, BRIC, Company Share by Revenue ($m), USD Constant, 2017 34
Table 9: Clinical Chemistry Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 36
Table 10: Clinical Chemistry Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 38
Table 11: Blood Test Strips - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 12: Clinical Chemistry Analyzers Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 42
Table 13: Enzyme Chemistry Reagents Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 44
Table 14: Feces Tests - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 46
Table 15: Substrates Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 48
Table 16: Therapeutic Drug Monitoring Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 50
Table 17: Urine Analysis Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 52
Table 18: Urine Testing - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 54
Table 19: Blood Test Strips - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Table 20: Clinical Chemistry Analyzers Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 58
Table 21: Enzyme Chemistry Reagents Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 60
Table 22: Feces Tests - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 62
Table 23: Substrates Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 64
Table 24: Therapeutic Drug Monitoring Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 66
Table 25: Urine Analysis Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 68
Table 26: Urine Testing - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 70
Table 27: Clinical Chemistry Market, Brazil, Volume (Units), Historic, 2010-2017 72
Table 28: Clinical Chemistry Market, Brazil, Volume (Units), Forecast, 2017-2024 74
Table 29: Blood Test Strips - Rapid Tests & POC Market, Brazil, Volume (Units), Historic, 2010-2017 76
Table 30: Clinical Chemistry Analyzers Market, Brazil, Volume (Units), Historic, 2010-2017 78
Table 31: Enzyme Chemistry Reagents Market, Brazil, Volume (Units), Historic, 2010-2017 80
Table 32: Feces Tests - Rapid Tests & POC Market, Brazil, Volume (Units), Historic, 2010-2017 82
Table 33: Substrates Market, Brazil, Volume (Units), Historic, 2010-2017 84
Table 34: Urine Testing - Rapid Tests & POC Market, Brazil, Volume (Units), Historic, 2010-2017 86
Table 35: Blood Test Strips - Rapid Tests & POC Market, Brazil, Volume (Units), Forecast, 2017-2024 88
Table 36: Clinical Chemistry Analyzers Market, Brazil, Volume (Units), Forecast, 2017-2024 90
Table 37: Enzyme Chemistry Reagents Market, Brazil, Volume (Units), Forecast, 2017-2024 92
Table 38: Feces Tests - Rapid Tests & POC Market, Brazil, Volume (Units), Forecast, 2017-2024 94
Table 39: Substrates Market, Brazil, Volume (Units), Forecast, 2017-2024 96
Table 40: Urine Testing - Rapid Tests & POC Market, Brazil, Volume (Units), Forecast, 2017-2024 98
Table 41: Clinical Chemistry Market, Brazil, Average Price ($), Forecast, 2017-2024 102
Table 42: Clinical Chemistry Market, Brazil, Distribution Share by Revenue ($m), USD Constant, 2017 104
Table 43: Clinical Chemistry Market, Brazil, Company Share by Revenue ($m), USD Constant, 2017 106
Table 44: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 108
Table 45: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 110
Table 46: Blood Test Strips - Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 112
Table 47: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 114
Table 48: Enzyme Chemistry Reagents Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 116
Table 49: Feces Tests - Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 118
Table 50: Substrates Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 120
Table 51: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 122
Table 52: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 124
Table 53: Urine Testing - Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 126
Table 54: Blood Test Strips - Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 128
Table 55: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 130
Table 56: Enzyme Chemistry Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 132
Table 57: Feces Tests - Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 134
Table 58: Substrates Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 136
Table 59: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 138
Table 60: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 140
Table 61: Urine Testing - Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 142
Table 62: Clinical Chemistry Market, China, Volume (Units), Historic, 2010-2017 144
Table 63: Clinical Chemistry Market, China, Volume (Units), Forecast, 2017-2024 146
Table 64: Blood Test Strips - Rapid Tests & POC Market, China, Volume (Units), Historic, 2010-2017 148
Table 65: Clinical Chemistry Analyzers Market, China, Volume (Units), Historic, 2010-2017 150
Table 66: Enzyme Chemistry Reagents Market, China, Volume (Units), Historic, 2010-2017 152
Table 67: Feces Tests - Rapid Tests & POC Market, China, Volume (Units), Historic, 2010-2017 154
Table 68: Substrates Market, China, Volume (Units), Historic, 2010-2017 156
Table 69: Urine Testing - Rapid Tests & POC Market, China, Volume (Units), Historic, 2010-2017 158
Table 70: Blood Test Strips - Rapid Tests & POC Market, China, Volume (Units), Forecast, 2017-2024 160
Table 71: Clinical Chemistry Analyzers Market, China, Volume (Units), Forecast, 2017-2024 162
Table 72: Enzyme Chemistry Reagents Market, China, Volume (Units), Forecast, 2017-2024 164
Table 73: Feces Tests - Rapid Tests & POC Market, China, Volume (Units), Forecast, 2017-2024 166
Table 74: Substrates Market, China, Volume (Units), Forecast, 2017-2024 168
Table 75: Urine Testing - Rapid Tests & POC Market, China, Volume (Units), Forecast, 2017-2024 170
Table 76: Clinical Chemistry Market, China, Average Price ($) Historic, 2010-2017 171
Table 77: Clinical Chemistry Market, China, Average Price ($), Forecast, 2017-2024 174
Table 78: Clinical Chemistry Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 177
Table 79: Clinical Chemistry Market, China, Company Share by Revenue ($m), USD Constant, 2017 179
Table 80: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 181
Table 81: Clinical Chemistry Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 183
Table 82: Blood Test Strips - Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 185
Table 83: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 187
Table 84: Enzyme Chemistry Reagents Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 189
Table 85: Feces Tests - Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 191
Table 86: Substrates Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 193
Table 87: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 195
Table 88: Urine Analysis Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 197
Table 89: Urine Testing - Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 199
Table 90: Blood Test Strips - Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Table 91: Clinical Chemistry Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 203
Table 92: Enzyme Chemistry Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 205
Table 93: Feces Tests - Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 207
Table 94: Substrates Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 209
Table 95: Therapeutic Drug Monitoring Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Table 96: Urine Analysis Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 213
Table 97: Urine Testing - Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 215
Table 98: Clinical Chemistry Market, India, Volume (Units), Historic, 2010-2017 217
Table 99: Clinical Chemistry Market, India, Volume (Units), Forecast, 2017-2024 219
Table 100: Blood Test Strips - Rapid Tests & POC Market, India, Volume (Units), Historic, 2010-2017 221
Table 101: Clinical Chemistry Analyzers Market, India, Volume (Units), Historic, 2010-2017 223
Table 102: Enzyme Chemistry Reagents Market, India, Volume (Units), Historic, 2010-2017 225
Table 103: Feces Tests - Rapid Tests & POC Market, India, Volume (Units), Historic, 2010-2017 227
Table 104: Substrates Market, India, Volume (Units), Historic, 2010-2017 229
Table 105: Urine Testing - Rapid Tests & POC Market, India, Volume (Units), Historic, 2010-2017 231
Table 106: Blood Test Strips - Rapid Tests & POC Market, India, Volume (Units), Forecast, 2017-2024 233
Table 107: Clinical Chemistry Analyzers Market, India, Volume (Units), Forecast, 2017-2024 235
Table 108: Enzyme Chemistry Reagents Market, India, Volume (Units), Forecast, 2017-2024 237
Table 109: Feces Tests - Rapid Tests & POC Market, India, Volume (Units), Forecast, 2017-2024 239
Table 110: Substrates Market, India, Volume (Units), Forecast, 2017-2024 241
Table 111: Urine Testing - Rapid Tests & POC Market, India, Volume (Units), Forecast, 2017-2024 243
Table 112: Clinical Chemistry Market, India, Average Price ($) Historic, 2010-2017 244
Table 113: Clinical Chemistry Market, India, Average Price ($), Forecast, 2017-2024 246
Table 114: Clinical Chemistry Market, India, Distribution Share by Revenue ($m), USD Constant, 2017 248
Table 115: Clinical Chemistry Market, India, Company Share by Revenue ($m), USD Constant, 2017 250
Table 116: Clinical Chemistry Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 252
Table 117: Clinical Chemistry Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 254
Table 118: Blood Test Strips - Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 256
Table 119: Clinical Chemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 258
Table 120: Enzyme Chemistry Reagents Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 260
Table 121: Feces Tests - Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 262
Table 122: Substrates Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 264
Table 123: Therapeutic Drug Monitoring Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 266
Table 124: Urine Analysis Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 268
Table 125: Urine Testing - Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 270
Table 126: Blood Test Strips - Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 272
Table 127: Clinical Chemistry Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 274
Table 128: Enzyme Chemistry Reagents Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 276
Table 129: Feces Tests - Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 278
Table 130: Substrates Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 280
Table 131: Therapeutic Drug Monitoring Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 282
Table 132: Urine Analysis Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 284
Table 133: Urine Testing - Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 286
Table 134: Clinical Chemistry Market, Russia, Volume (Units), Historic, 2010-2017 288
Table 135: Clinical Chemistry Market, Russia, Volume (Units), Forecast, 2017-2024 290
Table 136: Blood Test Strips - Rapid Tests & POC Market, Russia, Volume (Units), Historic, 2010-2017 292
Table 137: Clinical Chemistry Analyzers Market, Russia, Volume (Units), Historic, 2010-2017 294
Table 138: Enzyme Chemistry Reagents Market, Russia, Volume (Units), Historic, 2010-2017 296
Table 139: Feces Tests - Rapid Tests & POC Market, Russia, Volume (Units), Historic, 2010-2017 298
Table 140: Substrates Market, Russia, Volume (Units), Historic, 2010-2017 300
Table 141: Urine Testing - Rapid Tests & POC Market, Russia, Volume (Units), Historic, 2010-2017 302
Table 142: Blood Test Strips - Rapid Tests & POC Market, Russia, Volume (Units), Forecast, 2017-2024 304
Table 143: Clinical Chemistry Analyzers Market, Russia, Volume (Units), Forecast, 2017-2024 306
Table 144: Enzyme Chemistry Reagents Market, Russia, Volume (Units), Forecast, 2017-2024 308
Table 145: Feces Tests - Rapid Tests & POC Market, Russia, Volume (Units), Forecast, 2017-2024 310
Table 146: Substrates Market, Russia, Volume (Units), Forecast, 2017-2024 312
Table 147: Urine Testing - Rapid Tests & POC Market, Russia, Volume (Units), Forecast, 2017-2024 314
Table 148: Clinical Chemistry Market, Russia, Average Price ($) Historic, 2010-2017 315
Table 149: Clinical Chemistry Market, Russia, Average Price ($), Forecast, 2017-2024 317
Table 150: Clinical Chemistry Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2016-2017 319
Table 151: Clinical Chemistry Market, Russia, Company Share by Revenue ($m), USD Constant, 2017 321
Table 152: Clinical Chemistry Market Pipeline Products 325
Table 153: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 329

1.2 List of Figures
Figure 1: Clinical Chemistry Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2010-2024 19
Figure 2: Clinical Chemistry Market, BRIC, Category Comparison by Revenue ($m), USD Constant, 2010-2024 21
Figure 3: Clinical Chemistry Market, BRIC, Revenue ($m), Historic, USD Constant, 2010-2017 23
Figure 4: Clinical Chemistry Market, BRIC, Revenue ($m), Forecast, USD Constant, 2017-2024 25
Figure 5: Clinical Chemistry Market, BRIC, Volume (Units), 2010-2024 27
Figure 6: Clinical Chemistry Market, BRIC, Volume (Units), Historic, 2010-2017 29
Figure 7: Clinical Chemistry Market, BRIC, Volume (Units), Forecast, 2017-2024 31
Figure 8: Clinical Chemistry Market, BRIC, Company Share (%) 2017 33
Figure 9: Clinical Chemistry Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 35
Figure 10: Clinical Chemistry Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 37
Figure 11: Blood Test Strips - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 12: Clinical Chemistry Analyzers Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 41
Figure 13: Enzyme Chemistry Reagents Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 43
Figure 14: Feces Tests - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 45
Figure 15: Substrates Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 47
Figure 16: Therapeutic Drug Monitoring Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 49
Figure 17: Urine Analysis Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 51
Figure 18: Urine Testing - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 53
Figure 19: Blood Test Strips - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Figure 20: Clinical Chemistry Analyzers Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 57
Figure 21: Enzyme Chemistry Reagents Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Figure 22: Feces Tests - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 61
Figure 23: Substrates Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 63
Figure 24: Therapeutic Drug Monitoring Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 65
Figure 25: Urine Analysis Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 67
Figure 26: Urine Testing - Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 69
Figure 27: Clinical Chemistry Market, Brazil, Volume (Units), Historic, 2010-2017 71
Figure 28: Clinical Chemistry Market, Brazil, Volume (Units), Forecast, 2017-2024 73
Figure 29: Blood Test Strips - Rapid Tests & POC Market, Brazil, Volume (Units), Historic, 2010-2017 75
Figure 30: Clinical Ch

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

BRIC Clinical Chemistry Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model